Biogen shares rise on Alzheimer's candidate data MarketWatchBiogen's stock rises 4% after company releases new data on late-stage Alzheimer's drug CNBCNew details emerge on drug that may slow Alzheimer's disease NBCNews.comAs Alzheimer's Conference Kicks Off, All Eyes Are on Biogen's Drug XconomyNew details emerge on drug that may slow Alzheimer's disease The Associated PressView full coverage on Google News